Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells

Molecular Immunology

Volumn 53, Issue 4, 2013, Pages 387-397

  García Vallejo, Juan J ^a   Ambrosini, Martino ^a   Overbeek, Annemieke ^a   van Riel, Wilhelmina E ^a,d   Bloem, Karien ^a   Unger, Wendy W J ^a   Chiodo, Fabrizio ^b   Bolscher, Jan G ^c   Nazmi, Kamran ^c   Kalay, Hakan ^a   van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CIC BIOMAGUNE   (Spain)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cell surface molecules; Dendritic cells; Human; Rodent

Indexed keywords

CD209 ANTIGEN; DENDRIMER; GLYCOPEPTIDE; INTERCELLULAR ADHESION MOLECULE 3; LECTIN; POLYAMIDOAMINE;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CHEMICAL REACTION; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME; PRIORITY JOURNAL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; BIOLOGICAL TRANSPORT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL PROLIFERATION; DENDRIMERS; DENDRITIC CELLS; DRUG CARRIERS; GLYCOPEPTIDES; HUMANS; K562 CELLS; LECTINS, C-TYPE; LYSOSOMES; MICE; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE;

RODENTIA;

EID: 84867637264     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.09.012     Document Type: Article

References (56)

1. Appelmelk B.J., van Die I., van Vliet S.J., et al. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. Journal of Immunology 2003, 170(4):1635-1639.
2. Barnden M.J., Allison J., Heath W.R., et al. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunology and Cell Biology 1998, 76(1):34-40.
3. Basiji D.A., Ortyn W.E., Liang L., et al. Cellular image analysis and imaging by flow cytometry. Clinics in Laboratory Medicine 2007, 27(3):653-670. viii.
4. Berzi A., Reina J.J., Ottria R., et al. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models. AIDS 2012, 26(2):127-137.
5. Biricova V., Laznickova A. Dendrimers: analytical characterization and applications. Bioorganic Chemistry 2009, 37(6):185-192.
6. Bonifaz L., Bonnyay D., Mahnke K., et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. The Journal of Experimental Medicine 2002, 196(12):1627-1638.
7. Boscardin S.B., Hafalla J.C.R., Masilamani R.F., et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. The Journal of Experimental Medicine 2006, 203(3):599-606.
8. Burgdorf S., Kautz A., Böhnert V., et al. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8T cell activation. Science 2007, 316(5824):612-616.
9. Caminschi I., Proietto A.I., Ahmet F., et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008, 112(8):3264-3273.
10. Cao W., Zhang L., Rosen D.B., et al. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biology 2007, 5(10):e248.
11. Carbone F.R.F., Belz G.T.G., Heath W.R.W. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends in Immunology 2004, 25(12):655-658.
12. Dam T.K., Brewer C.F. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Glycobiology 2010, 20(3):270-279.
13. Dam T.K., Gerken T.A., Brewer C.F. Thermodynamics of multivalent carbohydrate-lectin cross-linking interactions: importance of entropy in the bind and jump mechanism. Biochemistry 2009, 48(18):3822-3827.
14. Dudziak D., Kamphorst A.O., Heidkamp G.F., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315(5808):107-111.
15. Engering A., Geijtenbeek T., van Vliet S., et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. Journal of Immunology 2002, 168(5):2118-2126.
16. Engering A., van Vliet S.J., Hebeda K., et al. Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. The American Journal of Pathology 2004, 164(5):1587-1595.
17. Fawcett J., Holness C.L., Needham L.A., et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992, 360(6403):481-484.
18. Geijtenbeek T.B., Kwon D.S., Torensma R., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100(5):587-597.
19. Geijtenbeek T.B., Torensma R., van Vliet S.J., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100(5):575-585.
20. Geijtenbeek T.B.H., van Vliet S.J., Koppel E.A., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. The Journal of Experimental Medicine 2003, 197(1):7-17.
21. Gringhuis S.I., den Dunnen J., Litjens M., et al. C-type lectin DC-SIGN modulates toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappa B. Immunity 2007, 26(5):605-616.
22. Hawiger D., Inaba K., Dorsett Y., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. The Journal of Experimental Medicine 2001, 194(6):769-779.
23. Heath W.R., Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nature Reviews Immunology 2001, 1(2):126-134.
24. Hogquist K.A., Jameson S.C., Heath W.R., et al. T cell receptor antagonist peptides induce positive selection. Cell 1994, 76(1):17-27.
25. Idoyaga J., Lubkin A., Fiorese, et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(6):2384-2389.
26. Joffre O., Nolte M.A., Spörri R., et al. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunological Reviews 2009, 227(1):234-247.
27. Kanazawa N. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. Journal of Dermatological Science 2007, 45(2):77-86.
28. Kraal G., Breel M., Janse M., et al. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. The Journal of Experimental Medicine 1986, 163(4):981-997.
29. Kretschmer K., Apostolou I., Hawiger D., et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nature Immunology 2005, 6(12):1219-1227.
30. Kurts C., Robinson B.W.S., Knolle P.A. Cross-priming in health and disease. Nature Reviews Immunology 2010, 10(6):403-414.
31. Li S., Zeng D. Chemoenzymatic enrichment of phosphotyrosine-containing peptides. Angewandte Chemie 2007, 46(25):4751-4753.
32. Luczkowiak J., Sattin S., Sutkeviciute I., et al. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection. Bioconjugate Chemistry 2011, 22(7):1354-1365.
33. Mahnke K., Qian Y., Knop J., et al. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003, 101(12):4862-4869.
34. Menon S., Rosenberg K., Graham S., et al. Binding-site geometry and flexibility in DC-SIGN demonstrated with surface force measurements. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(28):11524-11529.
35. Mitchell D.A., Fadden A.J., Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. The Journal of Biological Chemistry 2001, 276(31):28939-28945.
36. Mu F.T., Callaghan J.M., Steele-Mortimer O., et al. EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine fingers and contains a calmodulin-binding IQ motif. The Journal of Biological Chemistry 1995, 270(22):13503-13511.
37. Neefjes J., Jongsma M.L.M., Paul P., et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nature Reviews Immunology 2011, 11(12):823-836.
38. Ortyn W.E., Hall B.E., George T.C., et al. Sensitivity measurement and compensation in spectral imaging. Cytometry A 2006, 69(8):852-862.
39. Ortyn W.E., Perry D.J., Venkatachalam V., et al. Extended depth of field imaging for high-speed cell analysis. Cytometry A 2007, 71(4):215-231.
40. Paul P., van den Hoorn T., Jongsma M.L.M., et al. A genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell 2011, 145(2):268-283.
41. Rabinovich G.A., Croci D.O. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 2012, 36(3):322-335.
42. Robinson M.J., Sancho D., Slack E.C., et al. Myeloid C-type lectins in innate immunity. Nature Immunology 2006, 7(12):1258-1265.
43. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by GM-CSF plus IL-4 and downregulated by TNF-α. The Journal of Experimental Medicine 1994, 179:1109-1118.
44. Sancho D., Mourão-Sá D., Joffre O.P., et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. Journal of Clinical Investigation 2008, 118(6):2098-2110.
45. Sattin S., Daghetti A., Thépaut M., et al. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. ACS Chemical Biology 2010, 5(3):301-312.
46. Schaefer M., Reiling N., Fessler C., et al. Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection. Journal of Immunology 2008, 180(10):6836-6845.
47. Schreibelt G., Klinkenberg L.J.J., Cruz L.J., et al. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood 2012, 119(10):2284-2292.
48. Sheng K.-C.K., Kalkanidis M.M., Pouniotis D.S.D., et al. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. European Journal of Immunology 2008, 38(2):424-436.
49. Singh S.K., Stephani J., Schaefer M., et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Molecular Immunology 2009, 47(2-3):164-174.
50. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449(7161):419-426.
51. Unger W.W.J., van Kooyk Y. Dressed for success C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells. Current Opinion in Immunology 2011, 23(1):131-137.
52. Unger W.W.J., van Beelen A.J., Bruijns S.C., et al. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. Journal of Controlled Release 2012, 160(1):88-95.
53. van Kooyk Y., Rabinovich G.A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nature Immunology 2008, 9(6):593-601.
54. van Liempt E., Bank C.M.C., Mehta P., et al. Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Letters 2006, 580(26):6123-6131.
55. Viitala J., Carlsson S.R., Siebert P.D., et al. Molecular cloning of cDNAs encoding lamp A, a human lysosomal membrane glycoprotein with apparent Mr approximately equal to 120,000. Proceedings of the National Academy of Sciences of the United States of America 1988, 85(11):3743-3747.
56. Wang J., Zou Z.-H., Xia H.-L., et al. Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials. PLoS ONE 2012, 7(3):e32695.